Biogen Inc

NAS : BIIB
USA·Healthcare·Drug Manufacturers
$232.65
+3.62 (+1.76%)Oct 16 close
Market Cap
$34.14B
Enterprise Value
$36.40B
P/E (TTM)
41.17
P/B
1.85
Net Cash / (Debt)
−$7.07B
52-Week Range
$146 — $235
5-Year Range
$113 — $318
Avg Volume (3M)
1.25M
ListingsNASXTERLTS
Biogen Inc has no dividend payments on record. Any capital returned to shareholders comes through share repurchases — shown below.

Capital returns

Net buybacks = repurchases − stock issuance, fiscal-year cash flows. SBC shown for dilution context.

Total Shareholder Yield (TTM)
0.0%
Dividends 0.0% + Net buybacks 0.0%
Net Buyback (TTM)
$0
Gross $0 − Issuance $0
SBC (TTM)
$296M
Share-based compensation, dilution driver
Net share-count change % / yr

Splits (2)

DateRatioCumulative
1999-12-212:1×6 to today
2001-01-183:1×3 to today